FDA Approves Baxter’s HYQVIA for Treatment of Adults with Primary Immunodeficiency By Araceli Richardson|2020-08-18T00:57:59-07:00September 12, 2014|
Halozyme Announces Roche Marketing Authorization For MabThera SC For Patients With Common Forms Of Non-Hodgkin Lymphoma In European Union By Araceli Richardson|2020-08-18T00:57:59-07:00March 28, 2014|
